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Conclusions: Among patients with anterior circulation ischemic stroke undergoing thrombectomy, first-line thrombectomy with contact aspiration versus stent retriever did not result in an increased revascularization rate at procedure end.
Summary: This study was conducted to compare the two techniques head to head in regards to efficacy and adverse events when used as first-line endovascular treatment for revascularization of patients with acute ischemic stroke and large vessel occlusion. The Contact Aspiration vs Stent Retriever for Successful Revascularization (ASTER) study was a randomized, open-label, blinded end-point clinical trial conducted in eight comprehensive stroke centers in France from October 2015 to October 2016. Patients who presented with acute ischemic stroke and a large vessel occlusion in the anterior circulation within 6 hours of symptom onset were included. Patients were randomly assigned to firstline contact aspiration (n ¼ 192) or first-line stent retriever (n ¼ 189) immediately prior to mechanical thrombectomy in a 1:1 fashion. The primary outcome was the proportion of patients with successful revascularization defined as a modified Thrombolysis in Cerebral Infarction score of 2b or 3 at the end of all endovascular procedures. Secondary outcomes included degree of disability assessed by overall distribution of the modified Rankin Scale (mRS) score at 90 days, change in National Institutes of Health Stroke Scale (NIHSS) score at 24 hours, all-cause mortality at 90 days, and procedure-related serious adverse events. Among 381 patients randomized (mean age, 69.9 years; 174 women [45.7%]), 363 (95.3%) completed the trial. Median time from symptom onset to arterial puncture was 227 minutes (interquartile range, 180-280 minutes). For the primary outcome, the proportion of patients with successful revascularization was 85.4% (n ¼ 164) in the contact aspiration group vs 83.1% (n ¼ 157) in the stent retriever group (odds ratio, 1.20; 95% confidence interval [CI], 0.68-2.10; P ¼ 0.53; risk difference, 2.4%; 95% CI, À5.4% to 9.7%). Rescue treatment was needed in slightly more patients in the contact aspiration group (32.8% vs 23.8%, ns). For the clinical efficacy outcomes (change in NIHSS score at 24 hours, mRS score at 90 days) and adverse events, there were no significant differences between groups. Symptomatic intracranial hemorrhage occurred in 10 patients (5.3%) in the contact aspiration group and 12 patients (6.5%) in the stent retriever group (NS).
Comments: Vascular surgeons are faced with patient who experience stroke with a distal embolus that might be retrieved. The technical aspects mature with time and this study demonstrates that either aspiration or stent retriever thrombectomy can be used with similar efficacy but superiority was the study design and that was not proven. Prior to this study, stent retriever was the technique used in the original randomized controlled trials to demonstrate the benefits of embolus removal.
Repeated Measurements of Serum Concentrations of TNF-alpha, Interleukin-6, and Interleukin-10 in the Evaluation of Internal Carotid Artery Stenosis Progression Przemyslaw P, Lasek-Bal A. Atherosclerosis 2017;263:97-103.
Conclusions: Long-term trends in serum concentrations of IL-6 and IL-10 in patients with ICA stenosis helps predict stenosis progression and unfavorable changes in plaque morphology.
Summary:
The inflammatory process appears key in the development, progression and destabilization of atherosclerotic plaques. The aim of this study was to assess the importance of double-checked measurements of tumor necrosis factor alpha (TNFa), interleukin-6 (IL-6) and interleukin-10 (Il-10) serum levels in patients with internal carotid artery (ICA) stenosis to determine the dynamics of changes in the stenosis degree and ultrasound determined plaque morphology. This prospective study included 65 patients (20 women and 45 men), mean age 66.3 6 7.8 years, with symptomatic (39 individuals) or asymptomatic (26) atherosclerotic internal carotid artery stenosis above 50% confirmed by duplex imaging. All patients were treated with antiplatelets, statins, antihypertensives, and antidiabetic agents as appropriate. The carotid artery ultrasounds were performed during qualification and every 3 months to identify any progression of stenosis degree and changes in plaque morphology. Serum concentrations of TNF-alpha, IL-6 and IL-10 were measured during qualification and at six months. Calculations considered cytokine concentrations and their indices determined as relative differences of cytokine levels assessed in the first compared to the second tests. Patients with increasing degree of ICA stenosis had higher indices of IL-6 (0.77 vs 0.40; P ¼ .046) and IL-10 (1.28 vs 0.13; P ¼.02) than patients without any increase in the degree of stenosis. A statistically significant probability of unfavorable dynamics of atherosclerotic plaque morphology (potentially associated with plaque instability) was found for the indices of IL-6 (odds ratio [OR], 1.237; 95% confidence interval [CI], 1.045-1.465; P ¼ .013) and IL-10 (OR, 1.93; 95% CI, 0.994-3.747; P ¼ .048) in multivariate logistic regression model.
Comments: Serum indices of inflammation may become one factor that will influence the decision to operate in patients with vascular occlusive disease. Much work yet needs to be done to determine the appropriate inflammatory serum markers to measure that allows a better interventional algorithm outside of what patient symptoms and imaging can already provide. Without such critical analysis, serum markers will be an additional cost without improved quality care. Conclusions: There was no significant difference in mortality of symptomatic superior mesenteric artery (SMA) dissection patients without accompanying proof of bowel ischemia or aneurysm between interventional treatment and conservative treatment. An additional treatment is needed in a minority of patients receiving conservative treatment, however, more frequently than in those receiving endovascular treatment.
Outcomes of Treatment Strategies for Isolated
Summary: Isolated spontaneous SMA dissection without aortic dissection is being increasingly recognized. This study aimed to evaluate the latest clinical characteristics and optimal treatment. The authors searched the Cochrane Library, MEDLINE, and ClinicalTrial.gov databases through December 31, 2016, using the words: ''superior mesenteric artery'' and ''dissection.'' for articles presenting the treatment and outcomes of isolated SMA dissection published in English. Patient characteristics, treatments, follow-up, and prognoses were collected. Additionally, the authors compared mortality rates and assessed the need for additional interventions when comparing treatment strategies in symptomatic patients without accompanying proof of bowel ischemia or aneurysm. Fiftyone pertinent articles were identified consisting of 721 patients. Acute abdominal pain was observed in all 617 symptomatic patients and (31) 5% of the symptomatic patients had bowel ischemia, peritonitis, necrosis, aneurysmal rupture or aneurysm > 2 cm. The patients with complications were treated by endovascular (9) or surgical (22) means. The remaining 586 symptomatic patients were initial treated with conservative management (n ¼ 481; 82.1%), endovascular treatment (14.3%), catheterdirected infusion of medication (2.1%), and surgery (1.5%). Anticoagulants were more commonly used (57%) in conservative treatment than antiplatelet therapy (30%). Additional treatments were performed because of the recurrence or continuance of abdominal pain, aneurysmal change, and bowel ischemia. Additional treatment was needed in 18.1% of patients receiving conservative treatment and 2.4% of patients receiving endovascular treatment (P ¼ .0003) and generally during the initial episode. Mortality was not significantly different between each treatment strategy (P ¼ .92) with an overall rate of 0.69%. Asymptomatic patients
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were treated conservatively with no mortality reported. The most common follow-up modality was computerized tomography angiography. Because the articles found to evaluate were case series, the level of evidence is "very low" according to the GRADE system.
Comments: With the advent of improved imaging most notably computerized tomography, isolated dissections of many arterial beds have been recognized and, in general, are well managed by conservative treatments. Prior to such improved imaging, patients with abdominal discomfort (SMA dissection) often improved without a definitive diagnosis ever being confirmed. Now that we know the diagnosis, a conservative approach seems the best care for most patients without complications but with a need to reevaluate especially early in treatment to prevent unrecognized progression of disease.
Results of Stent Graft Placement to Treat Cephalic Arch Stenosis in Hemodialysis Patients With Dysfunctional Brachiocephalic Arteriovenous Fistulas
Jones RG, Willis AP, Tullett K, Riley RL. J Vasc Interv Radiol 2017;28:1417-21.
Conclusions:
The VIABAHN stent graft is a safe, effective, and durable device for treating cephalic arch stenosis when venoplasty fails.
Summary: To determine the effectiveness of the VIABAHN stent graft to treat cephalic arch stenosis in patients with dysfunctional brachiocephalic arteriovenous fistulas after inadequate venoplasty. Between 2012 and 2015, patients with failed venoplasty of symptomatic cephalic arch stenosis received a VIABAHN stent graft and are evaluated this retrospective study. Follow-up venography was performed at approximately 3, 6, and 12 months. Data were retrospectively analyzed with patency estimated using Kaplan-Meier and log-rank methodology. There were 39 patients included. Technical and clinical success was 100%. Primary target lesion patency was 85% (95% confidence interval [CI], 69%-93%), 67% (95% CI, 50%-80%), and 42% (95% CI, 25%-57%) at 3, 6, and 12 months. There was no significant difference in patency with regard to sex or age (P ¼ .8 and P ¼ .6, respectively). Primary assisted patency was 95% (95% CI, 82%-99%) at 3, 6, and 12 months. Access circuit primary patency was 85% (95% CI, 69%-93%), 67% (95% CI, 50%-80%), and 42% (95% CI, 25%-57%) at 3, 6, and 12 months. There was no significant difference in patency between patients with the stent graft as the first treatment episode in the cephalic arch and those that had previous intervention at this site (P ¼ .98). There were 48 repeat venoplasty procedures performed in the cephalic arch to maintain patency, including seven repeat VIABAHN insertions. No complications were encountered.
Comments: Placement of a Viabahn stent that high in the venous circuit of an arteriovenous fistula can eliminate options for subsequent access reconstructions if the stent is placed into the central vein. The authors note that placement into the central vein of more than 1 to 3 mm is not desired but emphasizing this fact will help to prevent undesired consequences. It might be better to consider an open patch of the area to improve outflow and preserve the deep veins for subsequent access if any potential compromise of the central vein would result. Conclusions: Approximately 1 in 5 patients hospitalized for critical limb ischemia (CLI) and undergoing revascularization is readmitted within 30 days. Readmission risk is influenced by CLI presentation, patient demographics, comorbidities, and in-hospital complications, but not by the mode of revascularization.
Thirty-Day Readmissions
Summary: Thirty-day readmission rates have gained increasing importance as a key quality metric. A significant number of patients are hospitalized for the management of critical limb ischemia (CLI), but limited data are available on the incidence, predictors, and causes of 30-day readmission after the initial hospitalization for CLI. Hospitalizations for a primary diagnosis of CLI during which patients underwent endovascular or surgical therapy (revascularization and/or amputation) and were discharged alive were identified in the 2013 to 2014 Nationwide Readmissions Databases. Incidence, reasons, and costs of 30-day unplanned readmissions were determined. Hierarchical logistic regression models were used to identify independent predictors of 30-day readmissions. Included were 60,998 (national estimate, 135,110) index CLI hospitalizations (mean age, 68.9 6 11.9 years; 40.8% women; 24.6% for rest pain, 37.2% for ulcer, and 38.2% for gangrene). The 30-day readmission rate was 20.4%. Presentation with ulcer or gangrene, age $65 years, female sex, large hospital size, teaching hospital status, known coronary artery disease, heart failure, diabetes mellitus, chronic kidney disease, anemia, coagulopathy, obesity, major bleeding, acute myocardial infarction, vascular complications, and sepsis were identified as independent predictors of 30-day readmission. Mode of revascularization was not independently associated with readmissions. Infections (23.5%), persistent or recurrent manifestations of peripheral artery disease (22.2%), cardiac conditions (11.4%), procedural complications (11.0%), and endocrine issues (5.7%) were the most common reasons for readmission. The inflation-adjusted aggregate costs of 30-day readmissions for CLI during the study period was $624 million.
Comments: These types of studies are always concerning to me because readmissions for planned but delayed minor amputation or debridement may be mislabeled as unplanned and so misrepresent the actual readmission rates. That being said, a rate of 20% is well within the literature reported rate and so is a major concern and expense. It is interesting that an open revascularization was not a risk factor for readmission since long incisions with resulting wound complications are often reported as a significant component of the need for readmissions. It is logical to suggest that these patients require special attention (multidisciplinary) to address the many potential reasons for readmission, but in particular, infection control in consort with the wound care provider, to prevent the need for readmissions.
Incidence of Myocardial Infarction After High-Risk Vascular Operations in Adults
Juo YY, Mantha A, Ebrahimi A, Ziaeian B, Benharash P. JAMA Surg 2017:1-8. doi:10.1001/jamasurg.2017.3360.
Conclusions:
The incidence of myocardial infarction (MI) did not significantly decrease in the past decade and has been consistently associated with worse clinical outcomes. Further inquiry into why advanced perioperative care did not reduce cardiac complications is important to quality patient care.
Summary: Several advances in perioperative cardiac care have been adopted to hopefully improve the outcome of patients requiring vascular operations. To examine the temporal trends of MI following high-risk vascular procedures, this retrospective cohort study was performed using data collected from first of January 2005 to end of December 2013 in the American College of Surgeons National Surgery Quality Improvement Program (NSQIP) database. Participating hospitals across the United States report a representative sampling of their preoperative, operative, and 30-day outcome data. A total of 90,303 adults who underwent a high-risk vascular procedure (open aortic surgery or infrainguinal bypass) during the study period were identified. Patients were divided into cohorts based on their year of operation, and their baseline cardiac risk factors and incidence of post-operative myocardial infarction (POMI) were compared. Cases from 2005 to 2014 in the database were eligible for inclusion if one of their Current Procedural Terminology codes matched any of the operations identified as a high-risk vascular procedure. The main exposure was the year of the operation. Other variables of interest included demographics, comorbidities, and other risk factors for MI. The primary outcome of interest was the incidence of POMI. Of the 90,303 patients included in the study; 22,836 (25.3%) 
